Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBIGAN with Latanoprost in Glaucoma
NCT01151904Phase 4Terminated
- Sponsor
- Allergan
- Start
- Nov 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of brimonidine tartrate + timolol maleate in Chronic Angle-Closure Glaucoma, sponsored by Allergan. Primary endpoint: Change From Baseline in Intraocular Pressure (IOP) at 12 weeks. Started Nov 2009; status: terminated.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Chronic Angle-Closure Glaucoma
Beyond the preview
Go deeper on NCT01151904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151904.